Decas, Bio-Nutra Settle LawsuitDecas, Bio-Nutra Settle Lawsuit
December 17, 2007
CARVER, Mass.Decas Botanical Synergies (DBS) and its parent company, Decas Cranberry Products Inc., settled a patent lawsuit filed by Bio-Nutra Technologies Inc., which claimed DBSs PACran product infringed a Bio-Nutra patent covering cranberry-based dietary supplements; Bio-Nutra supplies CranMAX® cranberry ingredients. Following pre-trial investigations into the method of manufacture and ingredient formulations, Bio-Nutra agreed to dismiss the claims against DBS and not bring similar actions against the company in the future. DBS (www.DecasBotanical.com) stated the resolution resulted in no restrictions, limitations or conditions on the sale or distribution of PACran, which is produced using a proprietary process to contain no less than 1.5 percent proanthocyanidins.
You May Also Like
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023